NorthCrest Asset Manangement’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-28,483
Closed -$257K 654
2025
Q1
$257K Buy
28,483
+179
+0.6% +$1.89K 0.01% 551
2024
Q4
$370K Sell
28,304
-699
-2% -$9.32K 0.01% 446
2024
Q3
$455K Buy
29,003
+3
+0% +$45 0.01% 412
2024
Q2
$392K Hold
29,000
0.01% 416
2024
Q1
$804K Sell
29,000
-450
-2% -$9.99K 0.03% 299
2023
Q4
$568K Hold
29,450
0.02% 359
2023
Q3
$476K Hold
29,450
0.02% 374
2023
Q2
$561K Hold
29,450
0.02% 341
2023
Q1
$428K Buy
29,450
+1,700
+6% +$30.4K 0.02% 387
2022
Q4
$542K Buy
27,750
+150
+0.5% +$2.93K 0.03% 264
2022
Q3
$665K Hold
27,600
0.04% 258
2022
Q2
$868K Hold
27,600
0.04% 232
2022
Q1
$1.22M Buy
27,600
+450
+2% +$19.3K 0.06% 178
2021
Q4
$1.18M Buy
+27,150
New +$1.06M 0.06% 201

Other funds holding ACH

NorthCrest Asset Manangement's ACH Position: Q2 2025 in Review

NorthCrest Asset Manangement sold out of Accendra Health (ACH) in Q2 2025, closing a stake of 28,483 shares — an estimated $257K sold.

NorthCrest Asset Manangement first reported a position in ACH in Q4 2021 and held it in 14 quarters. The position peaked at $1.22M in Q1 2022. 234 funds tracked by Wall St. Rank hold ACH as of Q2 2025.

  • NorthCrest Asset Manangement reported no remaining Accendra Health position as of Q2 2025 after selling out during the quarter.
  • NorthCrest Asset Manangement sold 28,483 Accendra Health shares in Q2 2025, an estimated $257K.
  • NorthCrest Asset Manangement first reported a position in Accendra Health in Q4 2021 and held it in 14 quarters.
  • NorthCrest Asset Manangement's Accendra Health position peaked at $1.22M in Q1 2022.
  • 234 funds tracked by Wall St. Rank held Accendra Health as of Q2 2025.

Based on NorthCrest Asset Manangement's 13F filing for Q2 2025, filed 10 Jul 2025.